Related Experiment Video

Updated: Aug 29, 2025

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
06:38

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on: April 12, 2017

13.7K

Renal cell carcinoma management: A step to nano-chemoprevention

Aisha Siddiqi1, Madhu Rani1, Preeti Bansal1

  • 1Department of Biosciences, Jamia Millia Islamia, Jamia Nagar, New Delhi 110025, India.

Life Sciences
|September 4, 2022
PubMed

Insights

Nanotechnology enhances phytochemical delivery for renal cell carcinoma (RCC) treatment. This approach improves bioavailability, offering new hope for treating this kidney cancer effectively.

Area of Science:

  • Oncology and Nanomedicine
  • Exploration of novel therapeutic strategies for cancer treatment.

Background:

  • Renal cell carcinoma (RCC) accounts for approximately 90% of kidney cancers.
  • Despite various treatments, RCC remains largely incurable due to therapy resistance.
  • Phytochemicals show anti-cancer properties but suffer from poor bioavailability due to their hydrophobic nature.

Purpose of the Study:

  • To review the application of nanotechnology in renal cell carcinoma (RCC) treatment.
  • To explore the role of phytochemicals as chemopreventive agents for RCC.
  • To discuss future prospects of nanomolecules in RCC prevention and cure.

Main Methods:

  • Literature review focusing on nanotechnology applications in RCC.
  • Analysis of phytochemicals with chemopreventive potential against RCC.
  • Examination of nanomaterial-based drug delivery systems for enhanced efficacy.

Main Results:

  • Nanotechnology offers targeted drug delivery, improving therapeutic outcomes in cancer medicine.
  • Nanotechnology can enhance the bioavailability and efficacy of hydrophobic phytochemicals.
  • The review highlights the potential of nanomolecules in advancing RCC treatment strategies.

Conclusions:

  • Nanotechnology presents a promising strategy to overcome the limitations of conventional RCC therapies.
  • Enhanced delivery of phytochemicals via nanocarriers can improve chemoprevention and treatment efficacy for RCC.
  • Future research in nanomolecules holds significant potential for the prevention and cure of renal cell carcinoma.
Keywords:
ChemopreventionNano-chemopreventionNanotechnologyPhytochemicalsRenal cell carcinomaTargeted drug delivery

More Related Videos

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy11:27

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy

Published on: April 29, 2014

16.8K
The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers12:22

The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers

Published on: January 22, 2013

33.7K

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
250
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K